Publication Name	World Journal of Hepatology
Manuscript ID	15479
Country	United States

Received	2014-11-27 11:11
Peer-Review Started	2014-11-29 17:27
To Make the First Decision	2015-01-08 14:01
Return for Revision	2015-01-14 11:55
Revised	2015-02-24 00:04
Second Decision	2015-06-29 08:17
Accepted by Journal Editor-in-Chief	2015-06-29 23:39
Accepted by Company Editor-in-Chief	2015-07-08 15:23
Articles in Press	2015-07-08 15:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-10 08:47
Publish the Manuscript Online	2015-07-24 19:52

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
Manuscript Source	Invited Manuscript
All Author List	Vikas Khullar and Roberto J Firpi
Funding Agency and Grant Number
Corresponding Author	Roberto J Firpi, MD, MS, AGAF, Section of Hepatobiliary Diseases and Transplantation, University of Florida College of Medicine, 1600 S.W. Archer Road, MSB- 440, Gainesville, FL 32608, United States. roberto.firpi@medicine.ufl.edu
Key Words	Cirrhosis; Diagnosis; Treatment; Simeprevir; Sofosbuvir; Ledipasvir; Liver transplantation; Hepatitis C virus
Core Tip	The treatment of chronic hepatitis C infection has undergone a revolution with the introduction of new and highly-effective therapies allowing for high rates of cure and relatively low adverse effects. While there is strong evidence for the treatment of patients without cirrhosis, limited studies and numbers are available for patients with cirrhosis; yet this is the group likely to benefit most from treatment. This paper focuses on the current evidence and regimens for the treatment of patients with cirrhosis and addresses the advantages and disadvantages of pursuing treatment.
Publish Date	2015-07-24 19:52
Citation	Khullar V, Firpi RJ. Hepatitis C cirrhosis: New perspectives for diagnosis and treatment. World J Hepatol 2015; 7(14): 1843-1855
URL	http://www.wjgnet.com/1948-5182/full/v7/i14/1843.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i14.1843

Full Article (PDF)	WJH-7-1843.pdf
Full Article (Word)	WJH-7-1843.doc
Manuscript File	15479-Review.docx
Answering Reviewers	15479-Answering reviewers.pdf
Audio Core Tip	15479-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	15479-Conflict-of-interest statement.pdf
Copyright License Agreement	15479-Copyright assignment.pdf
Peer-review Report	15479-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	15479-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	15479-Scientific misconduct check.pdf
Scientific Editor Work List	15479-Scientific editor work list.pdf